FMC (FMC) is back in focus after fresh guidance for the third quarter of 2026, a new board appointment, and an amended credit agreement tied to the planned sale of its India commercial business.
FMC’s recent guidance update, board appointment and credit agreement amendment come at a time of sharply reset investor expectations, with the share price down 47.3% over the past 30 days and the 1-year total shareholder return declining 83.0%. This indicates momentum has weakened rather than built.
Look beyond FMC and evaluate other beaten-down material stocks that still have solid fundamentals through our curated list of solid balance sheet and fundamentals (24 results).
The question now is simple. After FMC’s rapid slide to a US$5.05 share price and a planned India business sale, is it more sensible to step in today or wait for a clearer valuation reset ahead?
On Simply Wall St's most followed narrative, FMC’s fair value of $11.81 sits well above the last close at $5.05, so the gap between what the narrative implies and where the market is pricing the stock today is wide and very visible.
Strong volume growth is expected from recently launched proprietary actives such as fluindapyr, Isoflex and Dodhylex, together with management’s plan for four new active ingredients to reach US$300 million to US$400 million of revenue in 2026 and around US$800 million by 2027. This could increasingly support FMC revenue and EBITDA as these products scale.
See why 52 investors see FMC as 57% undervalued.
Result: Fair Value of $11.81 (UNDERVALUED)
Still, pressure from generic competition and high leverage, including guided 2026 interest expense of about US$275 million to US$285 million, could quickly weaken confidence in the FMC narrative.
Find out about the key risks to this FMC narrative.
Sentiment around FMC is clearly split, so act while the information is fresh and weigh the upside against the issues using our breakdown of 3 key rewards and 4 important warning signs
Do not let the FMC story be the only thing shaping your watchlist. Use this moment to refresh your wider opportunity set with data driven ideas.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com